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Reproductive events are among the most
well established ofbreast cancer risk factors.'
Often hypothesized to act by modifying
endogenous hormone levels,2 the occurrence
of such events during adolescence can have
different effects on risk in that the adolescent
and adult hormonal milieus can be quite dif-
ferent.3 Adolescent reproductive exposures
also may be markers for other breast cancer
risk factors, such as socioeconomic status
(SES), or highly correlated with other aspects
of exposure that are related to disease risk.
We explored the relationships of full-
term pregnancy, breast-feeding, miscarriage,
induced abortion, and oral contraceptive use
during adolescence with subsequent breast
cancer risk by analyzing data from the Car-
olina Breast Cancer Study, a population-
based case-control investigation. We also
examined potential effect modification by
age, race, and menopausal status.
Methods
The Carolina Breast Cancer Study was a
population-based, case-control study of
breast cancer in a contiguous 24-county
region ofcentral and eastern North Carolina.4
Women aged 20 to 74 years with a first
invasive, primary breast cancer diagnosis
between May 1993 and May 1996 were eligi-
ble; African American case patients and
patients younger than 50 years at diagnosis
were oversampled to increase the numbers in
these subgroups. Sampling fractions and ran-
domized recruitment techniques were used in
selecting case patients.56 The same methods
were used to sample controls from Division
of Motor Vehicle records (if the individuals
were younger than 65 years) and Medicare
records (if the individuals were 65 years or
older); these individuals were frequency
matched to the case patient age-race distrib-
ution. All study interviews were conducted in
person. Response rates, calculated among
women who were eligible and could be
located, were 77% among case patients and
68% among controls.7
We explored the relationship of breast
cancer with adolescent occurrence of a first
full-term pregnancy (gestation of7 months or
more), breast-feeding, miscarriage (gestation
of less than 7 months), induced abortion, and
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use of oral contraceptives (duration of 3
months or more). Adolescence was initially
defmed as the period between 10 and 19 years
of age, but the range was further divided if
sample size permitted. Questions directly
assessed age at first occurrence ofthe repro-
ductive event or exposure. Analyses of
breast-feeding were restricted to parous
women; analyses of miscarriage or induced
abortion were conducted regardless of, as
well as contingent on, gravidity status. An
analysis comparing adolescent induced
abortion with other adolescent pregnancy
outcomes (i.e., miscarriage or full-term preg-
nancy during adolescence) also was con-
ducted. Analyses of induced abortion and
oral contraceptive use were restricted to
women younger than 50 years because of the
very rare occurrence of these exposures dur-
ing adolescence among older women.
The 5 study exposures were examined as
potential confounders of one another, as were
other established or suspected breast cancer
risk factors, including age at menarche, body
mass, number offull-term births, attained edu-
cation, and breast cancer history in a first-
degree relative. Other adolescent exposures,
including comparative body size at 10 years of
age, physical activity at 12 years of age, and
age at initiation of cigarette smoking and alco-
hol consumption, also were considered. Meth-
ods previously employed by Newcomb et al.8
were used in imputing menopausal status for
women who had undergone a hysterectomy
but had at least 1 remaining ovary. Race
(African American vs others), menopausal
status (premenopausal vs postmenopausal),
and age at diagnosis-selection (younger than
50 years vs 50 years or older) were explored as
possible effect modifiers.
Logistic regression models with terms
for age (modeled in 5-year intervals), race,
and an offset to account for the sampling
design were used to determine relative odds
of disease.9' 0 In no instance did inclusion of
a potential confounder change the odds
ratio (OR) of interest by more than 15%
(our confounding criterion); thus, we pre-
sent odds ratios adjusted only for the design
variables. Effect modification was deemed
present if stratum-specific odds ratios dif-
fered 2-fold or more. Effect modification by
age was not explored for induced abortion
or oral contraceptive use because analyses
excluded individuals 50 years and older;
in analyses of miscarriage and induced
abortion restricted to nulliparous women,
evaluation of effect modification by race
was not possible owing to the small num-
bers of women experiencing such events.
We examined whether lifetime duration of
breast-feeding or time since most recent use
of oral contraceptives influenced the associ-
ations of each adolescent exposure with
breast cancer risk. In an attempt to disen-
tangle the relationships of adolescent full-
term pregnancy and breast-feeding with
breast cancer, we examined the relationship
of breast-feeding and breast cancer risk
among women with a first full-term preg-
nancy before 20 years of age.
Results
Although our goal was to accrue approx-
imately equal numbers of participants for
each race and age category, our final sample
contained fewer African American women
(335 case patients and 332 controls, as com-
pared with 527 White case patients and 458
controls) and fewer older women (356 case
patients 50 years and older and 383 controls,
as compared with 506 case patients younger
than 50 years and 407 controls). As expected,
case patients were more likely than controls
to report a family history ofbreast cancer, an
earlier age at menarche, and fewer full-term
pregnancies (data not shown).
Relative to women with a first full-term
pregnancy occurring between 20 and 29
years of age, those with a first full-term
pregnancy before 18 years of age (OR = 1.1,
95% confidence interval [CI] = 0.8, 1.5) or
at 18 or 19 years of age (OR= 1.0, 95%
CI = 0.8, 1.4) were not at reduced breast can-
cer risk. Among parous, premenopausal
women, breast-feeding before 20 years of
age, relative to no history of breast-feeding,
was associated with a substantial risk reduc-
tion (OR= 0.2, 95% CI = 0.1, 0.6); however,
this result was based on small numbers of
women reporting lactation during their teen
years (Table 1). This inverse relationship per-
sisted when lifetime duration of lactation
was considered and when analyses were
restricted to women with a first full-term
pregnancy before 20 years of age. In the lat-
ter analysis, adjustment for lifetime number
of full-term pregnancies and restriction to
women with parity of 2 or greater produced
similar results (data not shown).
Neither miscarriage nor induced abor-
tion before 20 years ofage, relative to no his-
tory of either event, conferred a meaningful
increase in risk (Table 2). The absence of a
relationship persisted in separate analyses
restricted to gravid, parous, or nulliparous
women. Comparison of induced abortions
with other adolescent pregnancy outcomes
also suggested no association.
African American women who used
oral contraceptives before 18 years of age
were at elevated risk of breast cancer rela-
tive to those who had never used oral con-
traceptives (OR = 2.0, 95% CI = 1.0, 4.3)
American Joumal of Public Health 1245
TABLE 1-Odds Ratios (ORs) and 95% Confidence Intervals (Cis) for the Association Between Age at First Lactation and
Breast Cancer Risk: Carolina Breast Cancer Study, 1993-1996
Premenopausal Postmenopausal
Case Patients Controls ORa (95% Cl) Case Patients Controls OR& (95% CI)
Never breast-fed 187 146 1.0 207 197 1.0
First breast-fed before 20 years of age 5 15 0.2 (0.1, 0.6) 58 66 0.8 (0.5,1.2)
Lifetime lactation duration <1 year 4 10 0.3 (0.1, 1.0) 25 37 0.6 (0.4,1.1)
Lifetime lactation duration .1 year 1 5 0.1 (0.0, 0.8) 33 29 1.0 (0.6,1.7)
First breast-fed at 20 years or older 112 95 0.8 (0.6,1.2) 98 128 0.7 (0.5,1.0)
Lifetime lactation duration <1 year 68 62 0.8 (0.5, 1.2) 62 79 0.7 (0.5, 1.1)
Lifetime lactation duration .1 year 44 33 0.9 (0.6, 1.6) 35 44 0.7 (0.4,1.1)
First full-term birth before 20 years of age
Never breast-fed 74 52 1.0 68 61 1.0
First breast-fed before 20 years of age 5 15 0.2 (0.1, 0.6) 57 66 0.7 (0.4,1.1)
First breast-fed at 20 years or older 4 10 0.3 (0.1, 0.9) 66 12 0.5 (0.2,1.3)
Note. Data are restricted to parous women with known or imputed menopausal status.
aAdjusted for race and age at diagnosis-selection, as well as sampling design.
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(Table 3). Among White women, no such
relationship was observed. Exclusion of
women whose first use occurred during
adolescence but after a full-term pregnancy
did not change the results (data not shown).
Among African American women who
used oral contraceptives during adoles-
cence, higher risks were observed for cur-
rent users and those who discontinued use
within the 10 years before diagnosis-selec-
tion (Table 3).
Discussion
In this population-based case-control
study of North Carolina women, adolescent
pregnancies neither increased nor decreased
breast cancer risk. Among premenopausal
women, breast-feeding before 20 years of age
was inversely associated with disease risk. Use
of oral contraceptives before 18 years of age
was positively associated with disease risk
only among AfricanAmerican women.
Our finding of no breast cancer risk
reduction with a first full-term pregnancy
before 18 years of age was observed in one"
of two 1,12 previous studies that explored the
relationship. We expected an inverse associa-
tion because first full-term pregnancies at
young ages are generally assumed to reduce
breast cancer risk owing to early breast cell
differentiation.'3 The considerable reduction
in breast cancer risk seen here among pre-
menopausal women who breast-fed as ado-
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TABLE 2-Odds Ratios (ORs) and 95% Confidence Intervals (Cls) for the Association Between Age at First Premature
Pregnancy Termination and Breast Cancer Risk: Carolina Breast Cancer Study, 1993-1996
All Women Nulliparous Women Gravid Women Parous Women
Case ORa Case ORa Case ORa Case ORa
Patients Controls (95% Cl) Patients Controls (95% CI) Patients Controls (95% Cl) Patients Controls (95% Cl)
Age at first
miscarriage, y
Never 637 548 1.0 111 72 1.0 546 487 1.0 526 476 1.0
<20 40 34 1.0 (0.6,1.6) 6 5 0.9 (0.3, 3.5) 40 34 1.0 (0.6,1.7) 34 29 1.1 (0.6,1.8)
.20 177 186 0.8 (0.6,1.0) 16 10 0.9 (0.4, 2.3) 177 186 0.8 (0.7,1.1) 161 176 0.8 (0.9,1.1)
Age at first induced
abortion, yb
Never 416 344 1.0 72 43 1.0 355 309 1.0 344 301 1.0
<20 19 11 1.2 (0.6, 2.7) 5 2 1.3 (0.2, 9.7) 19 11 1.3(0.6, 2.9) 14 9 1.2 (0.5, 2.9)
>20 65 45 1.1 (0.7,1.7) 14 6 1.2 (0.4, 3.9) 65 45 1.2 (0.8,1.8) 51 39 1.1 (0.7,1.8)
Outcome of first
adolescent pregnancyb,c




First induced abortion ... ... ... ... ... ... 19 11 1.2 (0.5, 2.9) 14 9 1.1 (0.4, 2.8)
before 20 years
aAdjusted for race and age at diagnosis-selection, as well as sampling design.
bRestricted to women younger than 50 years at diagnosis-selection.
cRestricted to women who had a pregnancy before 20 years of age.
TABLE 3-Odds Ratios (ORs) and 95% Confidence Intervals (Cis) for the Association Between Age at First Oral
Contraceptive (OC) Use and Breast Cancer, Among Women Younger Than 50 Years: Carolina Breast Cancer Study,
1993-1 996
White African American
Case Patients Controls ORa (95% Cl) Case Patients Controls ORa (95% CI)
Never used OCs 41 34 1.0 35 45 1.0
First OC use before 18 years of age 37 33 0.9 (0.4, 1.7) 36 20 2.0 (1.0, 4.3)
First OC use at 18 or 19 years of age 85 67 1.1 (0.6, 1.9) 39 35 1.4 (0.8, 2.8)
First OC use before 20 years of age
Regardless of TSLU 122 100 1.0 (0.6, 1.7) 75 55 1.6 (0.9, 2.9)
TSLU <10 yearsb 47 34 1.0 (0.5, 2.1) 33 16 2.2 (1.0, 5.3)
TSLU .10 years 75 66 1.0 (0.6,1.8) 42 39 1.4 (0.8, 2.7)
First OC use at 20 years or older
Regardless of TSLU 166 102 1.4 (0.8, 2.3) 65 71 1.2 (0.7, 2.1)
TSLU <10 yearsb 47 26 1.5 (0.8, 3.0) 23 19 1.7 (0.8, 3.7)
TSLU >10years 119 76 1.3 (0.8, 2.3) 42 52 1.1 (0.6,2.0)
Note. TSLU = time since last use.
aAdjusted for race and age at diagnosis-selection, as well as sampling design.
bIncludes current users.
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lescents also has been observed in another
study.8 Breast-feeding, regardless of timing,
may reduce risk through breast cell differenti-
ation and involution over and above that of
pregnancy, as well as by elimination of car-
cinogens via breast milk."4"15
Results of analyses of adolescent miscar-
riage and induced abortion, hypothesized to
increase breast cancer risk as a result ofbreast
cell proliferation without differentiation,'6
have ben quite varied. '7T20Ths may be due to
the use of different reference categories and
parity restrictions. We conducted a variety of
analyses, including those used by other investi-
gators17-20 (data not shown), yet none pro-
duced evidence of an association of breast
cancer with adolescent miscarriage and
induced abortion. Reporting error also may
influence analyses of induced abortion.2' The
extent of such error will probably vary across
studies for several reasons, including the legal-
ity of the procedure as well as the ages and
religious beliefs of participants. Our analysis
comparing adolescent induced abortion with
other potential pregnancy outcomes has not
been presented previously; we believe it may
be most relevant, however, because it directly
reflects the choice faced by pregnant teens.
Adolescent oral contraceptive use can
substantially increase levels ofcirculating ovar-
ian hormones, because menstrual cycles during
adolescence are often anovulatory.3 Hence,
adolescent oral contraceptive use is hypothe-
sized to increase breast cancer risk. A large
pooled analysis indicated that first use of oral
contraceptives before 20 years of age con-
ferred, of all initiation ages, the greatest
increase in risk, although the magnitude was
small and varied by amount oftime since most
recent use.2 The only study other than ours to
examine the relationship specifically among
AfricanAmerican women also observed a sub-
stantially elevated breast cancer risk.23 There is
little reason to believe that this association
should differ by race; therefore, other factors
may have influenced our observation of effect
modification, including the possibility of non-
response bias. Differences in educational
attainment between users and nonusers of oral
contraceptives were more extreme for Afican
American participants than for White partici-
pants, suggesting that inadequate control of
confounding, perhaps for SES, might have pro-
duced this discrepancy. However, adjustment
for education, current income, and a measure
of adolescent SES (head of household's occu-
pation) did not influence the results.
Given that many adolescent girls are sex-
ually active, the relationship of reproductive
events and exposures during the teen years
with future breast cancer risk is of potential
public health importance. A possible increase
in breast cancer among women who used oral
contaceptives during adolescence, particularly
African Americans, warrants furither study. D
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